David Turkaly
Stock Analyst at JMP Securities
(2.98)
# 1,550
Out of 4,761 analysts
142
Total ratings
41.35%
Success rate
0.28%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Market Perform | n/a | $382.78 | - | 2 | Feb 18, 2025 | |
| HAE Haemonetics | Maintains: Market Outperform | $125 → $100 | $63.02 | +58.68% | 11 | Feb 7, 2025 | |
| SNAP Snap Inc. | Reiterates: Market Outperform | $16 | $10.34 | +54.74% | 1 | Jan 29, 2025 | |
| LNTH Lantheus Holdings | Reiterates: Market Outperform | $112 | $78.23 | +43.17% | 8 | Jan 14, 2025 | |
| STE STERIS | Reiterates: Market Outperform | $265 | $220.56 | +20.15% | 16 | Nov 18, 2024 | |
| NVRO Nevro | Reiterates: Market Perform | n/a | $5.73 | - | 14 | Nov 12, 2024 | |
| ENOV Enovis | Initiates: Market Outperform | $62 | $42.71 | +45.17% | 1 | Oct 3, 2024 | |
| APYX Apyx Medical | Reiterates: Market Perform | n/a | $1.51 | - | 5 | Sep 16, 2024 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $23.76 | +110.44% | 9 | Sep 13, 2024 | |
| STIM Neuronetics | Maintains: Market Outperform | $7 → $3 | $4.13 | -27.36% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $15 → $12 | $2.72 | +341.18% | 5 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $17 → $20 | $18.00 | +11.11% | 6 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $40 → $35 | $21.13 | +65.64% | 13 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $23 → $20 | $13.02 | +53.61% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $17.84 | +79.37% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $17.95 | - | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $285 | $175.64 | +62.26% | 14 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $160 → $140 | $104.83 | +33.55% | 13 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $80.28 | - | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $2.70 | +48.15% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.14 | -45.30% | 1 | Oct 6, 2017 |
Stryker
Feb 18, 2025
Maintains: Market Perform
Price Target: n/a
Current: $382.78
Upside: -
Haemonetics
Feb 7, 2025
Maintains: Market Outperform
Price Target: $125 → $100
Current: $63.02
Upside: +58.68%
Snap Inc.
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $10.34
Upside: +54.74%
Lantheus Holdings
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $78.23
Upside: +43.17%
STERIS
Nov 18, 2024
Reiterates: Market Outperform
Price Target: $265
Current: $220.56
Upside: +20.15%
Nevro
Nov 12, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $5.73
Upside: -
Enovis
Oct 3, 2024
Initiates: Market Outperform
Price Target: $62
Current: $42.71
Upside: +45.17%
Apyx Medical
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $1.51
Upside: -
OrthoPediatrics
Sep 13, 2024
Reiterates: Market Outperform
Price Target: $50
Current: $23.76
Upside: +110.44%
Neuronetics
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $4.13
Upside: -27.36%
Aug 13, 2024
Maintains: Market Outperform
Price Target: $15 → $12
Current: $2.72
Upside: +341.18%
Aug 9, 2024
Maintains: Market Outperform
Price Target: $17 → $20
Current: $18.00
Upside: +11.11%
Jul 30, 2024
Maintains: Market Outperform
Price Target: $40 → $35
Current: $21.13
Upside: +65.64%
May 9, 2024
Maintains: Market Outperform
Price Target: $23 → $20
Current: $13.02
Upside: +53.61%
May 7, 2024
Reiterates: Market Outperform
Price Target: $32
Current: $17.84
Upside: +79.37%
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $17.95
Upside: -
Feb 23, 2024
Reiterates: Market Outperform
Price Target: $285
Current: $175.64
Upside: +62.26%
Nov 13, 2023
Maintains: Market Outperform
Price Target: $160 → $140
Current: $104.83
Upside: +33.55%
May 24, 2023
Reiterates: Market Perform
Price Target: n/a
Current: $80.28
Upside: -
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $2.70
Upside: +48.15%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.14
Upside: -45.30%